Micrima, the Bristol-based company developing a safe, low-cost system to improve the detection of breast cancer, has attracted a further £900,000 of investment following the success of clinical trials. The company, originally a spin-out from the University of Bristol, has secured fresh funding from a syndicate of experienced business angels...